Canada markets closed

CareDx, Inc (1K9.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
17.27-0.34 (-1.94%)
At close: 03:46PM CEST
Full screen
Previous Close17.61
Open16.99
Bid0.00 x 0
Ask0.00 x 0
Day's Range16.99 - 17.27
52 Week Range16.00 - 62.00
Volume2
Avg. Volume0
Market Cap907.72M
Beta (5Y Monthly)1.01
PE Ratio (TTM)N/A
EPS (TTM)-0.91
Earnings DateOct 26, 2022 - Oct 31, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est107.33
  • Business Wire

    CareDx to Host Symposium Covering Innovation in Multimodal Surveillance Including AiCAV for Post-Cardiac Transplant Care

    BRISBANE, Calif., September 29, 2022--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced it will host a symposium to describe the latest innovations in post-cardiac transplant care at the HFSA (Heart Failure Society of America) Annual Scientific Meeting 2022 taking place in Washington, D.C., September 30 - October 3

  • Business Wire

    Transplant Patients Experience Less Pain and Fewer Adverse Events with CareDx Non-Invasive Testing Solutions

    BRISBANE, Calif., September 27, 2022--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced a new peer-reviewed publication showing that AlloMap®, the industry’s only gene-expression profiling (GEP) blood test to non-invasively assess graft rejection by monitoring immune quiescence in heart transplant patients,1 result

  • Business Wire

    CareDx Congratulates Board Member Dr. Grace Colón for Being Named Healthcare Innovator on Top 50 Most Powerful Latinas List

    BRISBANE, Calif., September 26, 2022--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that Dr. Grace Colón, a member of its Board of Directors, has been named on the 2022 Most Powerful Latinas list by The Association of Latino Professionals For America (ALPFA).